Summary Cholecystokinin octapeptide (CCK-8) did not affect the behavioral syndrome of rats treated with pargyline and 5-hydroxytryptamine, while TRH produced a marked behavioral excitation under the same condition. However, the serotonin-potentiating effect of TRH was apparently suppressed by simultaneous administration of CCK-8.
Increased concentrations of serotonin in the brain are known to result in a behavioral hyperactivity syndrome. The behavioral effects of L-DOPA and 5-hydroxytryptophan (5-HTP) in monoamine oxidase inhibitor-pretreated mice are shown to be enhanced by TRH (HUIDOBRO-ToRo et al., 1974) . AGARWAL et al. (1977) suggested that antidepressant effects of TRH may be associated with increased synthesis and metabolism of serotonin in the brain. Although the existence of serotonin-dopamine interactions in the brain is not yet conclusive, we have observed that CCK-8 antagonizes the behavioral stimulatory effect of TRH (unpublished data). Our next step was to observe whether CCK-8 has a similar influence on the behavioral action of TRH in pargyline and 5-HTP-treated rats. the cerebral serotonin turnover (GRABOWSKA et al., 1973) . Moreover, WALDMEIER (1980) suggested that serotonergic modulation of dopamine is a generally occurring phenomenon in the brain. Although TRH has been shown by a number of investigators to stimulate dopamine metabolism, the influence of this tripeptide on serotonin metabolism has not been fully elucidated. AGARWAL et al. (1977) suggested that the effect of TRH is associated with increased synthesis and metabolism of serotonin in the brain. However, this report is insufficient for drawing conclusions as to the direct action of TRH on serotonin metabolism. As regards CCK-8, we have previously observed in rats that a CCK preparation had no particular influence on the brain serotonin content (KATSUURA et al., 1980) . However, this observation was insufficient for deciding the effect of CCK on serotonin metabolism, since serotonin turnover was not examined.
In the present study TRH was found to be extremely effective in potentiating the behavioral action of serotonin, while CCK-8 itself so far has shown no effect on the behavioral rating. However, CCK-8 showed a potent suppressive influence on the serotonin-potentiating action of TRH. Participation of the dopaminergic system in this phenomenon should be studied from the viewpoint of the functional interrelationship between these two monoaminergic systems. Although the problems remained unsolved, the fact that CCK-8 and TRH are functionally antagonistic suggests that both neuropeptides are involved in the physiological control of behavioral activities.
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